The Claudin18.2-targeted therapy…
The Claudin18.2-targeted therapy is the first CAR-T to win global [...]
Amid efforts in Germany to retool…
Amid efforts in Germany to retool the country’s drug spending, [...]
Before Aurobindo can complete its…
Before Aurobindo can complete its acquisition of Pennsylvania generics specialist [...]
Pfizer’s CFO Dave Denton will…
Pfizer’s CFO Dave Denton will officially depart in August, leaving [...]
With interest in automated cell…
With interest in automated cell therapy production beginning to build [...]
Name recognition and “familiarity”…
Name recognition and “familiarity” with Novo Nordisk’s oral Wegovy has [...]
Four years after Spero…
Four years after Spero Therapeutics received a complete response letter [...]
With good-but-not-great updated…
With good-but-not-great updated data on its approved oncology combo of [...]
Eighteen months after Novo Nordisk…
Eighteen months after Novo Nordisk purchased a plant in the [...]
GSK has launched the first…
GSK has launched the first direct-to-consumer TV spot for Exdensur, [...]